Skip to main content
Premium Trial:

Request an Annual Quote

CalbaTech Acquires MolecularWare

NEW YORK, June 9 - Biotech incubator CalbaTech said today that it has agreed to acquire privately held bioinformatics firm MolecularWare.


Financial terms of the acquisition were not disclosed.


CalbaTech said that MolecularWare, which markets a suite of software tools called DigitalGenome, was a key acquisition target because it "validates CalbaTech's business model in which it is seeking to acquire life-sciences-based companies that have near-term revenue or already have revenue and need a modest infusion of capital and a new structure."


CalbaTech's mission is to incubate companies that will generate sales or licensing revenues within two years and that require less than $1 million to bring a product to market. To date, the company has completed two other technology acquisition agreements: A license to slide-based diagnostics technology from Scottish diagnostics firm QICC; and a DNA isolation and extraction technology developed by J. Zoval, an associate inventor with CalbaTech.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.